Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Frelinger

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
JAMA|November 18, 2011
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular diseaseJessica L Mega, Willibald Hochholzer, Andrew L Frelinger, et al.
Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
High serum serotonin in sudden infant death syndromeRobin L Haynes, Andrew L Frelinger, Emma K Giles, et al.
Blood|June 1, 2013
The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiationBrenden W Smith, Sarah S Rozelle, Amy Leung, et al.
Blood|July 21, 2023
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndromeRoxane Labrosse, Julia I Chu, Myriam A Armant, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
JAMA|November 18, 2011
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular diseaseJessica L Mega, Willibald Hochholzer, Andrew L Frelinger, et al.
Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
High serum serotonin in sudden infant death syndromeRobin L Haynes, Andrew L Frelinger, Emma K Giles, et al.
Blood|June 1, 2013
The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiationBrenden W Smith, Sarah S Rozelle, Amy Leung, et al.
Blood|July 21, 2023
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndromeRoxane Labrosse, Julia I Chu, Myriam A Armant, et al.
Pageof 10